CMRX — Chimerix Income Statement
0.000.00%
Last trade - 00:00- $801.08m
- $669.44m
- $0.21m
Annual income statement for Chimerix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.37 | 1.98 | 33.8 | 0.324 | 0.212 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 33.4 | 0.324 | 0.212 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 49.9 | 175 | -135 | 93.4 | 96.8 |
| Operating Profit | -44.5 | -173 | 169 | -93.1 | -96.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -43.5 | -173 | 172 | -82.1 | -88.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -43.5 | -173 | 172 | -82.1 | -88.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -43.5 | -173 | 172 | -82.1 | -88.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -43.5 | -173 | 172 | -82.1 | -88.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.7 | -1.06 | 0.258 | -0.927 | -0.985 |